Cite
Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
MLA
Pernille Ravn, et al. “Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial.” Metabolites, vol. 12, no. 12, Nov. 2022, p. 1183. EBSCOhost, https://doi.org/10.3390/metabo12121183.
APA
Pernille Ravn, Freja Gram, Marianne S. Andersen, & Dorte Glintborg. (2022). Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial. Metabolites, 12(12), 1183. https://doi.org/10.3390/metabo12121183
Chicago
Pernille Ravn, Freja Gram, Marianne S. Andersen, and Dorte Glintborg. 2022. “Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial.” Metabolites 12 (12): 1183. doi:10.3390/metabo12121183.